White label – Pompe disease - ClinicalTrials.eu

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Not recruiting

3 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
Safety Study of Damoctocog Alfa Pegol for Children Aged 7 to 11 with Severe Hemophilia A

Not recruiting

3 1 1 1
Investigated Drugs:
- Damoctocog Alfa Pegol
Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Nivolumab
+4
Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

Not recruiting

2 1 1 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
Study of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer

Not recruiting

2 1 1
Investigated Drugs:
- Adagrasib
Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Not recruiting

3 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
+7
Study on the Effects of Benralizumab on Lung Function in Patients with Severe Eosinophilic Asthma

Not recruiting

3 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Benralizumab
Study on the Effects of Vonafexor, Rosuvastatin Zinc, and Iohexol on Kidney Function in Patients with Impaired Renal Function and Suspected MASH

Not recruiting

2 1 1 1
Investigated Diseases:
- Renal impairment
Investigated Drugs:
Study on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy

Not recruiting

3 1
Investigated Drugs:
- Phenylbutyrate
- Ursodoxicoltaurine
+4
Study of Olaparib and Abiraterone for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Hormone-refractory prostate cancer
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies